Toxicologic effects of gold nanoparticles in vivo by different administration routes

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 771-781

  Zhang, Xiao Dong ^a   Wu, Hong Ying ^a   Wu, Di ^a   Wang, Yue Ying ^a   Chang, Jian Hui ^a   Zhai, Zhi Bin ^a   Meng, Ai Min ^a   Liu, Pei Xun ^a   Zhang, Liang An ^a   Fan, Fei Yue ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Gold nanoparticles; In vivo; Toxicity

Indexed keywords

GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; ERYTHROCYTE COUNT; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOLOGY; LEUKOCYTE COUNT; MALE; MORPHOLOGY; MOUSE; NONHUMAN; ORGAN WEIGHT; SPLEEN WEIGHT; SURVIVAL; TOXICITY TESTING; WEIGHT REDUCTION; ANIMAL; BLOOD CELL; BODY WEIGHT; BONE MARROW CELL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NANOMEDICINE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALIA; MUS;

ADMINISTRATION, ORAL; ANIMALS; BLOOD CELLS; BODY WEIGHT; BONE MARROW CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; GOLD; HEMATOCRIT; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; ORGAN SIZE; PARTICLE SIZE;

EID: 79551678542     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S8428     Document Type: Article

References (53)

1. Danieland MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104: 293-346.
2. Eustis S, El-Sayed MA. Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev. 2006;35:209-217.
3. Hu M, Chen J, Li ZY, et al. Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem Soc Rev. 2006; 35:1084-94.
4. Anker JN, Hall WP, Lyandres O, Shah NC, Zhao J, van Duyne RP. Biosensing with plasmonic nanosensors. Nat Mater. 2008;7: 442-453.
5. Sokolov K, Follen M, Aaron J, et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003;63: 1999-2004.
6. Link S, El-Sayed MA. Shape and size dependence of radiative, non- radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem. 2000;19:409-453.
7. Pissuwan D, Valenzuela SM, Cortie MB. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends in Biotechnology.2006;24:62-67.
8. Zheng J, Zhang C, Dickson RM. Highly fluorescent, water-soluble, size- tunable gold quantum dots. Phys Rev Lett. 2004;93(077402): 1-4.
9. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128:2115-2120.
10. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49: N309-N315.
11. Juzenas P, Chen W, Sun YP, et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev.2008;60:1600-1614.
12. Liu CJ, Wang CH, Chien CC, et al. Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification. Nanotechnology. 2008; 19:295104-295109.
13. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:662-667.
14. Chen Z, Meng H, Xing G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006;163:109-120.
15. Cho EC, Au L, Zhang Q, Xia Y. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small. 2009;6:517-522.
16. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97:163-180.
17. Kim JS, Yoon TJ, Yu KN, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. 2006;89:338-347.
18. Yang ST, Fernando KAS, Liu JH, et al. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small. 2008;4: 940-944.
19. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15:897-900.
20. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325-327.
21. Pernodet N, Fang X, Sun Y, et al. Adverse effects of citrate/ gold nanoparticles on human dermal fibroblasts. Small. 2006;2: 766-773.
22. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small.2008;4:26-49.
23. Murphy CJ, Gole AM, Stone JW, et al. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc Chem Res. 2008;41: 1721-1730.
24. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci. 2007;95:300-312.
25. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta A. Cell selective response to gold nanoparticles. Nanomedicine. 2007;3: 111-119.
26. Male KB, Lachance B, Hrapovic S, Sunahara G, Luong HT. Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy. Anal Chem. 2008;80:5487-5493.
27. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662-668.
28. Pan Y, Neuss S, Leifert A, et al. Size-dependent cytotoxicity of gold nanoparticles. Small. 2007;3:1941-1949.
29. Manna S, Sarkar S, Barr J, et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription. Nano Lett.2005;5:1676-1684.
30. Schipper M, Nakayama-Ratchford N, Davis C, et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol. 2008;3:216-221.
31. Sayes C, Marchione Reed AK, Warheit D. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett.2007;7:2399-2406.
32. de Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29: 1912-1919.
33. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B Biointerfaces. 2008;66:274-280.
34. Kim JH, Kim KW, Kim MH, Yu YS. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology.2009;20:505101.
35. Chen YS, Hung YC, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett. 2009;4:858-864.
36. Cho WS, Kim S, Han BS, Son WC, Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett.2009;191:96-102.
37. Semmler-Behnke M, Kreyling WG, Lipka J, et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small. 2008;4:2108-2111.
38. Cho WS, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol.2009;236:16-24.
39. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials.2010;31:2034-2042.
40. Balogh L, Nigavekar SS, Nair BM, et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine. 2007;3:281-296.
41. Zhang G, Yang Z, Lu W, et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials. 2009;30:1928-1936.
42. Lipka J, Semmler-Behnke M, Sperling RA, et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials. 2010;31:6574-6581.
43. Zhang XD, Guo ML, Wu HY, et al. Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy. Int J Nanomedicine. 2009; 4:165-173.
44. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55-75.
45. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci. 2001;90:1927-1936.
46. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm.2000;50:147-160.
47. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010;393:649-655.
48. Shenoy D, Fu W, Li J, et al. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine. 2006;1: 51-57.
49. Lacerda SH, Park JJ, Meuse C, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano. 2010;4:365-379.
50. Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine.2009;5:162-169.
51. Gjetting T, Arildsen NS, Laulund C, et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/ cholesterolmediated gene transfection. Int J Nanomedicine. 2010;5: 371-383.
52. Hauck TS, Anderson RE, Fischer HC, Newbigging S, Chan WCW. In vivo quantum-dot toxicity assessment. Small. 2010; 6:138-144.
53. Fent GM, Casteel SW, Kim DY, et al. Biodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swine. Nanomedicine. 2009;5:128-135.